Login / Signup

Prolonged Secondary Stroke Prevention with Edoxaban: A Long-Term Follow-Up of the SATES Study.

Irene ScalaSimone BellaviaPier Andrea RizzoJacopo Di GiovanniMauro MonforteRoberta MorosettiGiacomo Della MarcaFabio PilatoAldobrando BroccoliniPaolo ProficeGiovanni Frisullo
Published in: Brain sciences (2023)
Edoxaban seems to be effective and safe in the long-term. The persistence rate of edoxaban therapy is optimal after more than three years of treatment.
Keyphrases
  • venous thromboembolism
  • atrial fibrillation
  • stem cells
  • combination therapy
  • mesenchymal stem cells
  • bone marrow
  • replacement therapy
  • brain injury
  • blood brain barrier
  • subarachnoid hemorrhage